Movahed Maryam S, Barghazan Saeed H, Adel Amin, Rezapour Aziz
Department of Health Economics, School of Health Management and Information Science, Iran University of Medical Sciences, Tehran, Iran.
Department of Health Economics, School of Health Management and Information Science, Iran University of Medical Sciences, Tehran, Iran.
Value Health Reg Issues. 2021 May;24:77-81. doi: 10.1016/j.vhri.2020.04.004. Epub 2021 Jan 28.
This study was conducted to estimate the annual societal costs in Iran associated with the treatment of ischemic and hemorrhagic stroke patients using a prevalence-based cost-of-illness framework.
A prevalence-based cost-of-illness framework was applied. Key model parameters included annual incidence of stroke; use of stroke therapies, medicines, and other medical care resources; work days missed; wage rates; and annual costs per patient. The outcomes measured were total societal costs, societal cost per year, and societal cost per patient-year.
For the studied 1940 patients, the economic burden of stroke in 2018 was roughly $4 081 124 in US dollars. Bearing in mind that there are about 100 000 cases of stroke, including new (35%) and old cases (65%) of 2 types of strokes, per year in Iran, the estimated economic impact is about $368 925 000. Lodging, medication, and consumables account for 69% of all direct medical costs ($299 959). The main cost factors were mortality costs (76.6%) and disability costs (14.7%).
The economic impact of stroke in Iran is considerable. The premature deaths and resulting disability from strokes accounted for the main productivity losses and all societal costs of stroke (approximately 91% of all costs). To control hypertension and decrease the burden of stroke, especially in elderly age groups, it is recommended that Iran look into how to focus on and expand healthy lifestyle choices.
本研究旨在使用基于患病率的疾病成本框架，估算伊朗与缺血性和出血性中风患者治疗相关的年度社会成本。
应用基于患病率的疾病成本框架。关键模型参数包括中风的年发病率；中风治疗、药物和其他医疗资源的使用；缺勤天数；工资率；以及每位患者的年度成本。所测量的结果为社会总成本、每年的社会成本以及每位患者每年的社会成本。
对于所研究的1940名患者，2018年中风的经济负担约为4081124美元。考虑到伊朗每年约有100000例中风病例，包括两种类型中风的新发病例（35%）和旧病例（65%），估计经济影响约为368925000美元。住宿、药物和耗材占所有直接医疗成本的69%（299959美元）。主要成本因素是死亡成本（76.6%）和残疾成本（14.7%）。
中风在伊朗造成的经济影响相当大。中风导致的过早死亡和残疾是主要的生产力损失以及中风的所有社会成本（约占所有成本的91%）的原因。为了控制高血压并减轻中风负担，特别是在老年人群体中，建议伊朗研究如何关注并扩大健康的生活方式选择。
